TARAProtara Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Protara Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TARAThis | $144M#6 | — | 0.9x#5 | 48.7x#6 | — | -28.7%#3 | -2189.6%#6 | -35.6%#2 | — | — | -52.4%#4 | — |
| ARTV | $206M#1 | — | 0.6x#2 | — | -100.0%#4 | -28.3%#2 | — | -24.1%#1 | — | — | 12.0%#2 | — |
| DTIL | $194M#2 | 21.7x#1 | 3.7x#7 | 5.7x#3 | -50.1%#3 | -738.0%#9 | -152.2%#1 | -88.3%#7 | — | — | -6.1%#3 | — |
| ACOG | $180M#3 | — | 3.4x#6 | 17.6x#5 | — | -39.8%#5 | -221.7%#3 | -39.0%#3 | — | — | 44.0%#1 | — |
| LIMN | $169M#4 | — | 563.0x#8 | — | — | -187.8%#8 | — | -3395.2%#8 | -170.3%#1 | — | — | — |
| STRO | $157M#5 | — | — | 1.5x#1 | 65.2%#1 | 15.9%#1 | -154.5%#2 | — | — | — | — | — |
| CMPX | $138M#7 | — | 0.8x#4 | — | -100.0%#4 | -34.7%#4 | — | -40.0%#4 | — | — | -79.5%#6 | — |
| ARMP | $114M#8 | — | — | — | — | -818.8%#10 | — | — | — | — | — | 0.1%#1 |
| VYGR | $113M#9 | — | 0.7x#3 | 2.8x#2 | -49.5%#2 | -84.2%#7 | -326.6%#4 | -77.6%#6 | — | — | -59.9%#5 | — |
| LENZ | $110M#10 | — | 0.6x#1 | 5.8x#4 | — | -65.0%#6 | -477.5%#5 | -42.8%#5 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice